The Science and Technology Committee splits its inquiry into genomics and genome-editing into two parts to allow full attention to be given to the distinct challenges and opportunities for human health, and for plants, animals and ecosystems.
100,000 Genomes Project
The Committee will focus its attention first on genomics and genome-editing in human health, before examining the technologies for plants, animals and ecosystems.
The first of these split inquiries will involve scrutiny of the Government's '100,000 Genomes Project', as well as the commercial, ethical, regulatory and social implications of genomics and gene-editing for human health.
Opportunity for revolutionising critical areas of our lives and livelihoods
Stephen Metcalfe MP, Chair of the Committee, said:
"Genomics and genome-editing are important areas of UK strength in the life-sciences—a focus of the Government's recent industrial Strategy green paper. Scrutiny of these technologies is needed because they offer the opportunity for revolutionising critical areas of our lives and livelihoods—from our agriculture to tackling genetic health conditions.
There are also, however, important regulatory issues at stake, potentially affected by the UK's exit from the EU, as well as ethical considerations. The importance of these issues means that undertaking two inquiries—on human health and then on animals and plants—will allow them to be given the attention they deserve."